Home
Search results “Lung cancer specialists in nyc”
TOP 10 Cancer Treatment Hospitals In The World
 
10:30
Top 10 Best Cancer Treatment Hospitals In The World Cancer is one of the most difficult diseases to manage, however, there are many hospitals in the world that can provide patients with the latest, cutting-edge treatments in order to give the best chance to fight against it. Doctors and scientists are always searching for and discovering new ways to treat cancer. According to InsiderMonkey, these are The 10 Best Cancer Treatment Hospitals In The World. 10. Peter Maccallum Health Centre, Australia Situated in Victoria, Australia, the Peter Maccallum Health Centre is the first public hospital in Australia that is solely dedicated to cancer patients. With more than 2,500 healthcare staff including over 580 clinical and laboratory researchers, Peter Mac is focused on providing better care, better treatments, and potential cures for cancer. Moorabbin, and Sunshine. 9. Oslo Comprehensive Cancer Centre, Norway At the heart of Oslo, Norway lies a high-tech cancer research facility. Located at the Oslo University Hospital, the Oslo Comprehensive Cancer Centre has more than 320 employees and seven research departments in its Institute for Cancer Research. Founded in 1954, the center boasts of its strong researches in the fields of biochemistry, cell and tumor biology, genetics, radiation biology, immunology, and cancer prevention. 8. Institut Gustave Roussy, France Located in Villejuif, France, the Institut Gustave Roussy is known as the premier European Cancer Centre. Innovation is at the core of this institution, leveraging scientific and technological advancements in the treatment of cancer. It was founded by Professor Gustave Roussy, the founding father of the cross-boundary working concepts and multidisciplinary patient management. 7. Netherlands Cancer Institute, The Netherlands Established in 1913, the Netherlands Cancer Institute (NKI) has been treating cancer patients for 103 years. With 650 scientists on board along with 185 specialists, this institute is no doubt one of the 10 best cancer hospitals in the world. It is the only hospital in the Netherlands solely dedicated for cancer. 6. Spanish National Cancer Research Center, Spain Located in Madrid, Spain, the Spanish National Cancer Research Center (CNIO) is known for applying technologically advanced treatments for cancer patients. 5. Roswell Park Cancer Institute, The US The Roswell Park Cancer Institute is the country’s first cancer center. Founded in 1898, the center takes pride in its multidisciplinary approach to treating cancer. The institute was built on the vision of eminent surgeon Dr. Roswell Park who rightfully predicted that cancer would become the leading cause of death in the U.S. and around the world. 4. Abramson Cancer Center, The US Located at the Hospital of the University of Pennsylvania, the Abramson Cancer Center is known for its innovation, cutting-edge technology, and translational medicine. It has one of the biggest clinical trial programs in the U.S. The Center has been named as “Translational Centers of Excellence” for lung, breast, blood, and pancreatic cancers. 3. Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, The US Headquartered in Baltimore, Maryland, the Johns Hopkins Hospital Sidney Kimmel Comprehensive Cancer Center is one of the premier cancer facilities in the U.S. It can accommodate more than 980 patients and has more than 46,600 admissions yearly. 2. Memorial Sloan Kettering Cancer Center, The US Located in New York City, the Memorial Sloan Kettering Cancer Center is one of the leading cancer hospitals in the country. It can accommodate more than 470 patients with over 24,000 admissions yearly. It was established in 1884 and was then known as New York Cancer Hospital. Memorial Sloan is known as the world’s oldest and largest private cancer center, treating patients for over 130 years. The strength of this hospital is their exceptional patient care, innovative research, and outstanding educational programs. They provide genetic counseling and psychological support to their cancer patients. Some of their leading cancer treatments include robot-assisted surgery, minimal access surgery, intraoperative radiation therapy, artemis intraoperative imaging technology, and immune checkpoint blockade therapy. 1. University of Texas MD Anderson Cancer Center, The US Recognized as the number one cancer hospital in the world, the University of Texas MD Anderson Cancer Center has a laser-focused mission to eliminate cancer in Texas, the country, and the world. It was established in 1941 by Monroe Dunaway Anderson, a banker and cotton trader who left a substantial amount of money for healthcare. Produced by: https://www.toptruths.com https://www.advexon.tv Contact us: https://www.facebook.com/toptruths/ Playlists: TOP Educational: https://goo.gl/Te6pVF TOP 10: https://goo.gl/csRZMy TOP Cotroversial: https://goo.gl/8kzcBg TOP Science & Tech: https://goo.gl/R3Rthw TOP TRUTHS: https://goo.gl/Rikg2D
Views: 9970 TOP TRUTHS
NYC Doctors Failed to Diagnose Lung Cancer; NY Medical Malpractice Attorney Oginski Explains
 
03:47
NYC Clinic Doctors Failed to Diagnose Lung Cancer; NY Medical Malpractice Attorney Oginski Explains http://www.Oginski-Law.com/ NY Medical Malpractice & Personal Injury Trial Lawyer 516-487-8207 Email: Gerry@Oginski-Law.com The patient continued to cough. She was a heavy smoker. Nothing she did changed her symptoms. She decided to go to a world-famous hospital in New York City around the corner from where she lived. She thought she'd get world-class care there. What she didn't know was that the doctors in the clinic were young doctors-in-training and did not have the experience and knowledge necessary to recognize her true condition. Each month the patient would return and follow the young doctor's instructions on what to do and what medications to take. Each month, the patient's symptoms either stayed the same or got progressively worse. Each month she returned, she saw a new doctor in training. They were never the same doctors. That was one of the key problems. By the time her condition deteriorated and she was finally diagnosed, she had stage IV metastatic lung cancer. The sad reality is that the doctors who were treating her looked back at her original records when she had first appeared in the clinic. They agreed that if her condition had been recognized when she first appeared and had the proper workup, she would have been at Stage I-Stage II which would have been fully treatable with an excellent prognosis. Unfortunately for this patient, her lung cancer advanced to the point where it actually killed her. Watch the video to learn more... Here's a cardiac malpractice case where I was able to achieve a $6 million dollar settlement for my client: http://www.oginski-law.com/video/cardiac-malpractice-in-ny.cfm Here's a foot surgery case where a Westchester, NY jury awarded my client $1.55 million dollars for her pain and suffering: http://ow.ly/azKg6 To learn more about how medical malpractice cases work in the state of New York, I encourage you to explore my educational website, ‪http://www.Oginski-Law.com‬. If you have legal questions, I invite you to pick up the phone and call me at 516-487-8207 or by email at Gerry@Oginski-Law.com. This is what I do every day and I'd be happy to chat with you. Law Office of Gerald Oginski 25 Great Neck Road, Ste. 4 Great Neck, NY 11021 516-487-8207 Email: Gerry@Oginski-Law.com
Views: 461 Gerry Oginski
Lung Cancer Surgery
 
08:17
Combined Left Pneumonectomy for Local Advaced Lung Cancer (T4N2M0) with Extensive Lymphadenectomy
Views: 137797 Oleg Kshivets
Suffering from Lung Cancer 30 sec
 
00:31
Dying from smoking is rarely quick and never painless. When smoking leads to lung cancer, you can suffer every minute of every day. 285,000 Americans are living with the misery of lung cancer caused by smoking. Quit Smoking Today. For help, call 311 or 1-866-NY-Quits or visit nyc.gov and search NYC Quits.
Views: 80847 NYCHealth
Lung Cancer Stage 3 - Drs. Schneider and Scheff
 
07:32
Bryan J. Schneider, M.D., Medical Oncologist at NewYork-Presbyterian/Weill Cornell Medical Center and Ronald J. Scheff, M.D., Medical Oncologist and Hematologist at NewYork-Presbyterian/Weill Cornell Medical Center, discuss the diagnosis and treatment of a stage 3 lung cancer patient.
What Cancer Patients Should Know: Latest Immunotherapy News from ASCO 2018
 
10:44
Our panel of immunotherapy experts discusses the latest cancer immunotherapy advances featured at the world’s largest oncology conference—the 2018 annual meeting of the American Society of Clinical Oncology (ASCO)—with topics including combination immunotherapy, biomarker development, CAR T cell therapies, and new approaches to immune-based cancer treatment. Panelists include Charles G. Drake, M.D., Ph.D., of NewYork-Presbyterian/Columbia University Medical Center, and Catherine Diefenbach, M.D., and Jeffrey S. Weber, M.D., of the Perlmutter Cancer Center at NYU Langone Health. Jill O'Donnell-Tormey, Ph.D., of the Cancer Research Institute, moderates. We present this video as part of the Answer to Cancer patient and caregiver education program of the Cancer Research Institute, and feature it as part of our sixth annual global awareness campaign, Cancer Immunotherapy Month, in June. This panel was recorded on June 4, 2018, in Chicago, IL.
Going beyond PD-L1 testing for lung cancer immunotherapy
 
05:02
Jürgen Wolf, MD, University Hospital of Cologne, Cologne, Germany, talks about strategies to select the patients most likely to benefit from immune checkpoint inhibitors, a class of drugs that activate the immune system against tumour cells. Current selection strategies are based on the expression levels of PD-L1 in the tumour, with higher levels of expression associated with a higher likelihood of response to treatment. However, Prof Wolf points out that PD-L1 expression is not always associated with a good response to immunotherapy. There are cases of PD-L1 positive patients who do not respond to treatment and conversely, cases of PD-L1 negative-patients who benefit from treatment. Therefore, there is a need for better predictive biomarkers to enable more precise treatment decisions. Prof Wolf discusses two strategies for patient selection that go beyond PD-L1 testing. The first is overall mutational burden, the sum of all mutations present in a tumour cell. The higher the mutation burden, the higher the probability of a response to immunotherapy. The second strategy aims to look at the tumour micro-environment and the multiple interactions that take place between the different components of the immune system. Transcriptome analysis looks at the activity of the tumour’s whole genome as opposed to gene mutations. By looking at activity of the whole genome, Prof Wolf’s research aims to identify patterns that differentiate patients who will respond to immunotherapy from those who will not. These strategies are currently under investigation and not yet ready to be translated into clinical practice. Recorded at the 2017 meeting of the British Thoracic Oncology Group (BTOG) in Dublin, Ireland.
Views: 665 VJOncology
Lungs cancer
 
01:03
Medical
Views: 301 Ejaz Ahmad
VA Lung Cancer Surgery & Aftermath April 2015
 
01:52:41
VA Hospital Lung Cancer Surgery Surgery Malpractice
Views: 673 Nyc Labretš
Reverse the Damage - Lung Cancer 30 sec
 
00:33
8 hours after you quit smoking, your blood oxygen level returns to normal. In 3 months your lung function improves. Quit smoking today. For help, call 311 or visit http://nyc.gov/nycquits .
Views: 108362 NYCHealth
Lung Cancer & New York City Kitchens: Sheila Bushkin-Bedient MD, MPH
 
15:06
Sheila Bushkin-Bedient, MD, MPH received her medical degree from the Autonomous University of Guadalajara in 1980, the Mount Sinai School of Medicine in June 1982 and her Masters of Public Health from the SUNY Albany School of Public Health. She has been an active member of the Medical Society of the State of New York (MSSNY) for 15 years, where she has served on many committees concerned with public health education and advocacy. She has authored and co-authored research studies in professional journals and lectured on a wide range of topics on environmental health issues such as exposure to chemical contaminants and ionizing radiation in early childhood associated with cancer later in life. She is currently a member of the Institute for Health and the Environment at the State University at Albany, and Concerned Health Professionals of New York. This is part 2 of this series.
Views: 298 TheEnvironmentTV
GRACEcast-087_Lung-Cancer_Detection and Work-Up of Lung Nodules, by David Yankelevitz
 
33:18
http://cancergrace.org/ Dr. David Yankelevitz, Professor of Radiology at Mount Sinai Medical Center in New York City, reviews technical advances in CT screening for lung nodules, features suggesting whether a nodule is benign or malignant, and the CT-guided biopsy procedure.
Clinical Insights on Newer Immunotherapies in Lung Cancer
 
03:17
Benjamin P. Levy, MD, highlights the use of immunotherapy for lung cancer treatment and expectations regarding its toxicities versus standard chemotherapy.
Views: 128 AJMCtv
Patient to Patient: What You Need to Know About Cancer Immunotherapy
 
45:36
How does a cancer diagnosis interrupt your life? Why choose immunotherapy? Two patients offer two very different perspectives on life with cancer, choosing a clinical trial, and figuring out what's next in life. In this webinar designed for patients and caregivers, T.J. Sharpe and Donna Fernandez share their experiences with cancer immunotherapy as well as share advice for patients currently seeking or receiving immunotherapy treatment. T.J. Sharpe, was diagnosed with metastatic melanoma in 2012, just weeks after the birth of his second child. Not satisfied with the standard of care treatments offered to him, he and his family began exploring immunotherapy. Two clinical trials later, he is living a full life, now on maintenance Keytruda, devoting the bulk of his time to his family and to melanoma advocacy. T.J. writes a blog for philly.com called Patient 1. (The name of his blog was inspired by the first clinical trial he enrolled in at Moffit Cancer Center, in which he was the first patient ever to receive Yervoy and TIL (tumor-infiltrating lymphocytes, a type of adoptive cell transfer).) Donna Fernandez was first diagnosed with stage 4 lung cancer in 2012, when she went to the doctor believing she had a thyroid problem. At the time, Donna was working full time and doing dog agility several nights a week and every weekend. Her tumors did not respond to chemotherapy, and when faced with beginning a second chemotherapy regimen, Donna instead enrolled in an immunotherapy trial of nivolumab (Opdivo). Donna responded immediately. Her scans show that the tumors have remained stable. Donna continues training with her two dogs, Cotton and Barney. She says, “Opdivo has let me live my life exactly how I want to. People talk about a “new normal” after cancer, but I don’t have a new normal. I’m still living my old normal.” The "Cancer Immunotherapy and You" webinar series is produced by the Cancer Research Institute and is made possible with generous support from Bristol-Myers Squibb, with additional support from Regeneron, Sanofi Genzyme, and Adaptimmune. Browse our Cancer Immunotherapy and You Webinar Series playlist on YouTube or visit the Webinars page on our website to see other webinars in this series. http://www.cancerresearch.org/webinars
CROI 2015 Lung Cancer in HIV
 
18:20
Keith Sigel, MD, Mt Sinai School of Medicine, New York City, New York; Elizabeth Yanik, National Cancer Institute, Bethesda, MD; Keri Althoff, PhD, Johns Hopkins University, Baltimore, MD; Panel Host – Christopher Brennan, IFARA, Portland, OR Discussing the evolution of population level behavioral risk factors that impact late stage cancers in HIV infected populations. To view this and other videos be sure to subscribe to stay up to date. You can also visit our website at accesshiv.org where we have archived our work at various other conferences.
Views: 214 AccessHIV
Doctor: The Lung Cancer & Breast Cancer Connection
 
00:39
Find out the connection between Lung Cancer & Breast Cancer from Dr. Patel, Assistant Professor of Hematology/Oncology at Northwestern. Go to http://www.EmpowHer.com to get more Lung Cancer interviews. Share your story & send this to a friend.
Views: 161 EmpowHER
John Stossel Recovering After Lung Cancer Surgery
 
00:30
Fox Business Network personality John Stossel is being treated for lung cancer. He shared that his doctors told him the cancer was "caught early" and that he'll be "fine." Recently 1/5th of one of his lungs was removed. He went on to describe the medical care he's received at New York-Presbyterian Hospital as "excellent," but the customer service isn't good. http://hosted2.ap.org/APDEFAULT/4e67281c3f754d0696fbfdee0f3f1469/Article_2016-04-20-US--People-John%20Stossel-Cancer/id-f28c84d7c11b4561837666bc67561175 http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Views: 799 Wochit News
New York Cancer Specialists
 
00:31
We are thrilled to debut our latest television spot showcasing the exciting transition and expansion from NSHOA Cancer Center to NEW YORK CANCER & BLOOD SPECIALISTS. Enjoy!
Personalized Medicine Used for the Treatment of Lung Cancer - Joshua R. Sonett, MD
 
06:01
This video describes personalized medicine and describes how it is used to treat lung cancer. For more information, visit http://www.columbiathoracic.org or call 212-305-3408
Tumor Board: A Panel of Experts Discuss Cancer Treament
 
02:37
Joshua Sonett, M.D., F.A.C.S., Director, Lung Transplant Program at NewYork-Presbyterian/Columbia University Medical Center; Bryan J. Schneider, M.D., Medical Oncologist at NewYork-Presbyterian/Weill Cornell Medical Center; Balazs Halmos, M.D., Section Chief, Thoracic Oncology at NewYork-Presbyterian/Columbia Medical Center; Bhupesh Parashar, M.D., Radiation Oncologist, NewYork-Presbyterian/Weill Cornell Medical Center; Ronald J. Scheff, M.D., Director, Fellowship Training Program Weill Cornell Medical College; Nasser Khaled Altorki, M.B., B.Ch., Director, Lung Cancer Institute at NewYork-Presbyterian/Weill Cornell Medical College, explain how the tumor board, at NewYork-Presbyterian in New York City, plans the course of treatment for each patient with lung or esophageal cancer.
The Lung Cancer Program at Maimonides
 
00:31
Our Lung Cancer specialists use the most innovative and minimally invasive techniques. We offer the full array of services — from state-of-the-art diagnostic, medical, radiation and surgical services, to psychosocial support that treats the whole patient, not just the disease. Learn about the Lung Cancer Screening Program at Maimonides: http://bit.ly/2tw0dhC Learn about lung cancer treatment at the Maimonides Cancer Center: http://bit.ly/2taP9Ha Find a Maimonides cancer specialist: http://bit.ly/2roA0Rv
Top 10 Cancer Treatment Institute / Hospital / Medical Center (Part 2)
 
06:17
Top 10 Cancer Treatment Institute / Hospital / Medical Center Watch PART 1 Here: http://bit.ly/cancermedicalcenters Cancer is one of the most difficult diseases to manage, however, there are many hospitals in the world that can provide patients with the latest, cutting-edge treatments in order to give the best chance to fight against it. Doctors and scientists are always searching for and discovering new ways to treat cancer. According to Insider Monkey, these are The 10 Best Cancer Treatment Hospitals In The World: 5. Roswell Park Cancer Institute, The US The Roswell Park Cancer Institute is the country’s first cancer center. Founded in 1898, the center takes pride in its multidisciplinary approach to treating cancer. The institute was built on the vision of eminent surgeon Dr. Roswell Park who rightfully predicted that cancer would become the leading cause of death in the U.S. and around the world. The center is known for its Quality Improvement Program that aims to provide “high-quality, cost-effective patient care, while preserving and enhancing the dignity, humanity, and knowledge of the patients served.” The Institute is launching the first clinical trial in the U.S. for a lung cancer treatment called CIMAvax-EGF® vaccine. 4. Abramson Cancer Center, The US Located at the Hospital of the University of Pennsylvania, the Abramson Cancer Center is known for its innovation, cutting-edge technology, and translational medicine. It has one of the biggest clinical trial programs in the U.S. The Center has been named as “Translational Centers of Excellence” for lung, breast, blood, and pancreatic cancers. Translational medicine is the process of translating research-based medical discoveries into a cure. It was named a Comprehensive Cancer Center in by the National Cancer Institute in 1973 and has maintained that premier status ever since. The Abramson Cancer Center is home to over 400 basic, translational, and clinical scientists who work tirelessly to find out the pathogenesis of cancer. Some of its advanced technologies include HIV oncology program, bone marrow and stem cell transplant program, melanoma and pigmented lesion program, GI cancer program, cancer risk evaluation program, largest Proton Therapy Center, genitourinary cancer program, immunotherapy, and telegenic program. 3. Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, The US Headquartered in Baltimore, Maryland, the Johns Hopkins Hospital Sidney Kimmel Comprehensive Cancer Center is one of the premier cancer facilities in the U.S. It can accommodate more than 980 patients and has more than 46,600 admissions yearly. Johns Hopkins is synonymous with excellent patient care and research, and the Sidney Kimmel Comprehensive Cancer Center is a testament to that. Established in 1973, the center is a world leader in deciphering the mechanisms of cancer and discovering new ways to treat it. It was one of the first institutions to earn the status Comprehensive Cancer Center and recognized as a Center of Excellence. The center has a wide spectrum of specialty programs for adults and children with cancer. It has a Cancer Counselling Center, palliative care programs, and a patient-family suite for those traveling from different states or countries. The center is also known for its Art of Healing program, merging technology to heal the body and a nurturing environment to heal the human spirit. Among the hospital’s advanced treatments are cell cycle regulation, robot-assisted cancer surgeries, DNA repair, signal transduction, plasmapheresis, immunology, stem cell transplants, and melanoma vaccine research. 2. Memorial Sloan Kettering Cancer Center, The US Located in New York City, the Memorial Sloan Kettering Cancer Center is one of the leading cancer hospitals in the country. It can accommodate more than 470 patients with over 24,000 admissions yearly. It was established in 1884 and was then known as New York Cancer Hospital. Memorial Sloan is known as the world’s oldest and largest private cancer center, treating patients for over 130 years. 1. University of Texas MD Anderson Cancer Center, The US Recognized as the number one cancer hospital in the world, the University of Texas MD Anderson Cancer Center has a laser-focused mission to eliminate cancer in Texas, the country, and the world. It was established in 1941 by Monroe Dunaway Anderson, a banker and cotton trader who left a substantial amount of money for healthcare. Produced by: https://www.toptruths.com https://www.advexon.tv Contact us: https://www.facebook.com/toptruths/ Playlists: TOP Educational: https://goo.gl/Te6pVF TOP 10: https://goo.gl/csRZMy TOP Cotroversial: https://goo.gl/8kzcBg TOP Science & Tech: https://goo.gl/R3Rthw TOP TRUTHS: https://goo.gl/Rikg2D
Views: 1985 TOP TRUTHS
Governor Cuomo Announces Groundbreaking Clinical Trial of Cuban-Developed Lung Cancer Treatment
 
33:29
October 26, 2016, Buffalo - Governor Cuomo announced that the Buffalo-based Roswell Park Cancer Institute will launch a groundbreaking clinical trial of CIMAvax-EGF – a Cuban-developed lung cancer treatment.
Views: 960 NYGovCuomo
Multi-Part Thoracic Cancer Series from NewYork-Presbyterian
 
01:32
http://www.orlive.com/nyp/videos/treating-esophageal-and-lung-cancer-advancements-in-care1?cmpid=nep-2884 Every Wednesday at 12:00pm ET until August 24th, check out a new segment on "Treating Esophageal and Lung Cancer: Advancements in Care". This special thoracic cancer web series is brought to you by NewYork-Presbyterian.
Lenox Hill Hospital Launches Lung Cancer Screening Program
 
01:56
Carmen Stanko was hit with two tumors in her lungs in less than a year. The first was advanced and required one-third of her lung be removed. If it had been caught earlier she may have had a better prognosis. People like Carmen are the reason Lenox Hill Hospital opened its Lung Cancer Screening Program, to catch the disease in its earliest stages and save lives.
Views: 304 Northwell Health
Skin Cancer NYC - (212) 644-6454 - New York, NY
 
05:25
http://www.nycdermatologist.com/skin-cancer.html (212) 644-6454 Welcome to Skin Cancer NYC at Pre- Skin Cancer at Skin Cancer Treatment Center in New York, NY headed by a board certified Dermatologist with international acclaim as a world leader in all types of Skin Cancer Treatment. best skin cancer dermatologist nyc best hospital for skin cancer sloan kettering melanoma doctors basal cell cancer top skin cancer doctors skin cancer doctor near me free skin cancer screening new york skin cancer images melanoma specialist nyc melanoma screening nyc sloan kettering melanoma doctors top melanoma specialist melanoma treatment center rankings sloan kettering dermatology department best melanoma oncologist molesafe nyu pre skin cancer pictures pre skin cancer treatments pre skin cancer terms what does pre skin cancer look like pre skin cancer photos pre skin cancer on nose pre skin cancer keratosis pre skin cancer spots basal cell cancer pictures basal cell cancer treatment basal cell cancer on nose basal cell cancer surgery basal cell lung cancer basal cell carcinoma cancer superficial basal cell cancer basal cell cancer photos squamous cell carcinoma cancer squamous cell skin carcinoma squamous cell lung carcinoma squamous cell carcinoma throat cancer squamous cell carcinoma skin cancer prognosis squamous cell carcinoma cancer pictures squamous cell carcinoma tongue cancer squamous cell carcinoma cancer ribbon
Views: 192 Skin Cancer NYC
Lung Cancer Rates In Younger Women On The Rise
 
02:19
The alarming trend has experts concerned. CBS2's Dr. Max Gomez reports.
Views: 354 CBS New York
Clinical trial for lung cancer vaccine coming to Buffalo
 
01:17
Clinical trial for lung cancer vaccine coming to Buffalo ◂ WKBW provides local news for all of Western New York, Buffalo, NY and the Niagara Falls NY region 7 Eyewitness News is Buffalo's Source for news, sports, weather, and good things happening every day. For more download the WKBW mobile app: iPhone: http://bit.ly/iOS-wkbw Android: http://bit.ly/wkbw-android
Staten Island Viewpoint: Lung Cancer Screening (2015)
 
28:58
Hosts: Dr. Bruce E. Eisenberg, Camille T. Zarrelli. Guests: Nancy Rooney RN, Nurse Navigator, Dr. Keith Diaz MD, Pulmonary Medicine. Staten Island ranks highest for smoking and lung cancer in NYC. It is never too late to quit. Lung cancer screening saves lives!
Views: 217 adpny
Dr. Garon Discusses Immunotherapy as Salvage Treatment for Advanced Lung Cancer
 
01:14
Edward B. Garon, MD, director of Thoracic Oncology at the Jonsson Comprehensive Cancer Center at UCLA, discusses the possibility of administering PD1 or PD-L1 blockades as a third-line or salvage therapy for patients with advanced lung cancer. While it is understood that these agents may work in the second-line setting for some patients, to-date, researchers and clinicians are still unsure if some patients would see more of a benefit holding treatment off until a later setting. However, Garon mentioned that by looking through the abundance of data from recent clinical trials, researchers might be able to find
Views: 134 OncLiveTV
Asbestos Lung Cancer || Hospital NJ
 
00:16
Asbestos Lung Cancer Hospital NJ
Immunotherapy Research Update Expert Panel – NYC Immunotherapy Patient Summit 2017
 
01:02:37
Our Immunotherapy Patient Summit expert panel—Dr. Michael Postow, Dr. Robert Vonderheide, Dr. Dmitriy Zamarin, and Dr. Leena Gandhi (moderator)—delved into the current developments of immunotherapy for different types of cancer. Meet the Experts Leena Gandhi, M.D., Ph.D. is the director of thoracic medical oncology at NYU’s Langone Medical Center and an associate professor of medicine at NYU’s Laura and Isaac Perlmutter Cancer Center. Dr. Gandhi’s work has mainly focused on lung cancer including using checkpoint inhibitors for patients with this type of cancer. She was a lead investigator in the crucial phase 1 of a clinical trial which explored the usefulness of using PD-L1 as a biomarker for patients receiving anti-PD-L1 checkpoint immunotherapy and continues to work on evaluations of potential biomarkers to refine use of immunotherapies. Our lung cancer immunotherapy webinar with Dr. Gandhi: http://bit.ly/2uO6Oo3 Michael Postow, M.D., is a physician at Memorial Sloan Kettering Cancer Center in the Melanoma and Immunotherapeutics Oncology Service. Dr. Postow completed his fellowship on clinical research in melanoma and immunotherapy at Memorial Sloan Kettering where he has been leading clinical trials involving immunotherapeutic agents. Additionally he is editor-in-chief for the journal “Clinical Skin Cancer” and serves on the editorial board of the “Journal for the Immunotherapy of Cancer.” Our Ask A Scientist about clinical trials series with Dr. Postow: http://bit.ly/ScientistPostow Robert Vonderheide, M.D., D.Phil. , director of the Abramson Cancer Center of the University of Pennsylvania Perelman School of Medicine, is an expert in immunobiology. His work explores how CD40, GM-CSF, PD-1, CTLA-4 and CD25 regulate the tumor environment and immune activity. He has also helped translate his research into novel immunotherapies that have been used to treat pancreatic cancer and melanoma patients. Our pancreatic cancer immunotherapy webinar with Dr. Vonderheide: http://bit.ly/2uKbOhD Dmitriy Zamarin, M.D., Ph.D., is a medical oncologist at Memorial Sloan Kettering Cancer Center who specializes on gynecologic cancers, including cervical, ovarian, and endometrial cancer. Dr. Zamarin’s research focuses on the novel ways to use the immune system to fight cancer, and he is involved in clinical trials that evaluate the use of novel immunotherapy drugs in cancer patients.
Medical breakthroughs aide treatment of lung cancer
 
02:25
More people in the United Sates die from lung cancer than any other type of cancer. Likewise on Guam, lung cancer accounts for the highest amount of death amongst men and women, therefore it is important to detect lung cancer early so that it may be cured with surgery and treated through personalized treatment.
Views: 228 kuamnews
Esophageal Cancer: Diagnosis, Treatment and Recovery
 
10:31
Joshua Sonett, M.D., F.A.C.S., Chief, Thoracic Surgery at NewYork-Presbyterian/Columbia University Medical Center and Nasser Khaled Altorki, M.B., B.Ch., Chief, Division of Thoracic Surgery at NewYork-Presbyterian/Weill Cornell Medical Center in New York City, discuss the hospital's approach for treating esophageal cancer.
Dr. Tracey Evans on Treatment of Poor PS and Elderly Patients With Lung Cancer
 
01:31
Tracey L. Evans, MD, associate professor of clinical medicine, University of Pennsylvania Health System, discusses treatment of poor performance status (PS) and elderly patients with lung cancer.
Views: 150 OncLiveTV
Dr. Powell on Important Future Directions in Lung Cancer
 
01:16
Charles Powell, MD, director, Mount Sinai-National Jewish Health Respiratory Institute, sheds light on what he feels oncologists should be tackling in the future of treating patients with lung cancer. Powell discusses the importance of managing patients with pulmonary nodules in a systematic and standardized way, given that there is an increased prevalence as a result of CT screening. He also urges oncologists in this space to take what they are learning about advanced lung cancer and apply it to early-stage disease, as the cure rates have been shown to be much higher in that patient population.
Views: 86 OncLiveTV
Lung Cancer Misdiagnosed And Why We Did Not Take The Case
 
02:34
Important Issue To Know In Maryland Lung Cancer Misdiagnosis Cases Maryland Medical Malpractice Trial Attorneys medicalinjury@bostonlawllc.com 301-850-4832 www.bostonlawllc.com The second opinion doctor all but admits that your first doctor clearly missed your lung cancer. Is this a slam dunk type of case if you decide to pursue a medical malpractice case in Maryland against your first doctor or hospital? The short answer is no, it may not be a slam dunk type of case because the type of cancer you have developed will play a very important role in the analysis. What is one of the big issues in these types of cases? Maryland law requires that you must prove, regardless of the actions of the doctor, that you would you would have had a 51% chance or higher of beating the cancer. Based on this, it is easy to see that the type of cancer presented makes a big difference. Because small cell lung cancer is a type of cancer that spreads really quickly, even if the doctor does everything right, most patients will not live more than 5 years top when diagnosed with this type of cancer. As a result of this, we declined to take the lung cancer misdiagnosis case because our client would not have had a good chance of beating the small cell lung cancer she was diagnosed with by her second opinion doctor. To speak to us further about whether your cancer misdiagnosis is medical malpractice, this is what we invite you to do. If it happened in Maryland, pick up the phone and give us a call. We can be reached at 301-850-4832. We answer questions like yours regarding Maryland medical malpractice law all the time and we would be glad to listen to your story. Boston Law Group, LLC 2 Wisconsin Circle Suite 700 Chevy Chase, Maryland 20815 Email: medicalinjury@bostonlawllc.com
Views: 120 BostonLawGroupLLC
Every Cancer Can be Cured in Weeks explains Dr. Leonard Coldwell
 
06:56
Help support iHealthTube so we can continue to make free videos: https://www.patreon.com/ihealthtube Dr. Leonard Coldwell states that every cancer can be cured within 16 weeks. Dr. Coldwell states how that's possible in this video. He recommends using natural cancer cures as opposed to traditional cancer treatments. Is this a cure for cancer? Take a look!
Views: 6835853 iHealthTube.com
Miscommunication Between Doctor & Nurse Caused Patient Death in Hospital in New York City
 
05:57
Miscommunication Between Doctor & Nurse Caused Patient Death in Hospital in New York City http://www.oginski-law.com/library/one-example-of-medical-error-due-to-miscommunication.cfm NY Medical Malpractice & Personal Injury Lawyer Gerry Oginski Explains 516-487-8207 Email: Gerry@Oginski-Law.com The instructions were simple. The doctor wrote the instructions down. They were right there in the patient's chart. It said "Patient to be restrained to bed at ALL times." That was the doctor's order. He expected everyone to follow that order. It was for the patient's benefit. It was to protect the patient. Otherwise, he might get up out of bed, fall and hit his head. You see, he'd recently been diagnosed with lung cancer. He just had an episode of delirium. He was confused. He was now in the hospital being evaluated for his confusion. His doctor wanted him to have a CAT scan. To see what was going on in his brain. Did the cancer extend to his brain? Was there something else going on in his brain? He didn't know. His doctor did know that the patient was at risk for falling. All because of his confusion. As per the doctor's orders, he was physically restrained to his bed. When he went for his CAT scan test, they had to remove his restraints. Instead of returning the patient back to his original room on a medical floor, the technician was told the patient had been assigned to a new floor and a new unit. The technician, following instructions, returned the patient to a new floor and a new unit. The receiving nurse along with the technician, transferred the patient to a bed. They tucked him in, covered him and said goodnight. They told him that a few hours later, a nurse would be by to check on his vital signs. When somebody finally came by hours later to check on his vital signs, they found the patient on the floor, unconscious with massive bruising all around his face and head. Learn how failing to read hospital records resulted in miscommunication and medical error that resulted in this patient's death. Watch the video to learn more... Here's a cardiac malpractice case where I was able to achieve a $6 million dollar settlement for my client: http://www.oginski-law.com/video/cardiac-malpractice-in-ny.cfm To learn more about how accident & medical malpractice cases work in the state of New York, I encourage you to explore my educational website, http://www.oginski-law.com/library/one-example-of-medical-error-due-to-miscommunication.cfm If you have legal questions and your matter happened here in New York and you're thinking about bringing a lawsuit, I invite you to pick up the phone and call me at 516-487-8207 or by email at Gerry@Oginski-Law.com. This is what I do every day and I'd be happy to chat with you. Law Office of Gerald Oginski 35 South Drive Great Neck, NY 11021 516-487-8207 Email: Gerry@Oginski-Law.com
Views: 247 Gerry Oginski
Lung Cancer & New York City Kitchens: Jeff Zimmerman
 
17:54
Jeff Zimmerman has spent his legal career practicing environmental law, with the Environmental and Natural Resources Division of the U.S. Department of Justice, as in-house environmental counsel for Atlantic Richfield Company, Occidental Petroleum Corporation and, over the last 6 years, in a practice focused on representing environmental and citizen groups on issues related to water resources, land use regulation and unconventional natural gas development. He has worked on the environmental issues associated with all aspects of the nuclear fuel cycle. In addition to his law degree, he possesses an undergraduate degree in physics. This video is part one of a series.
Views: 172 TheEnvironmentTV
My Cancer treatment. BCG immunotherapy. A look inside.
 
07:01
My treatments at Sloan Kettering in NYC. BCG treatment. A look inside the treatment room.
Views: 20025 Peter Connors
Treatment for NSCLC After Progression on Immunotherapy
 
05:22
Roy Herbst, MD, PhD, and Everett Vokes, MD, describe their approach to treating non–small cell lung cancer that progresses on a PD-1 or PD-L1 inhibitor.
Views: 290 OncLiveTV
Voices of Value Speak Up: Non-Small Cell Lung Cancer
 
01:31:20
Voices of Value Speak Up: Non-Small Cell Lung Cancer is the first part of a national six-event program presented by Patients Rising and Aimed Alliance. Our goal is simple: protect every patient's right to access life-saving treatments. If you are a cancer patient, caregiver or curious consumer -- we invite you to join us for a free evening of dinner, drinks and value. You'll hear real patients speaking out on value and why it is important to answer institutions, specifically the Institute for Clinical and Economic Review (ICER), that are attempting to create roadblocks between patients and innovative treatments. We'll shine a light on policy proposals that could limit or ration the care that you need. We'll show you how you can get involved in the process by Speaking Up! Our goal is to unite patients into a single voice that can lead the conversation on the future of health care. We believe that the true measure of value in our health care system starts with the concerns and goals of patients.
Views: 423 Patients Rising
Thyroid Cancer Treatments and Suggestions | Omega Hospitals | Health File | TV5 News
 
22:11
In today's Health File Programme, Watch discussion on Thyroid Cancer Treatments and Suggestions with Dr. Mohan Vamsi from Omega Hospitals. Watch Health File, A Featured Programme by TV5, Where Doctors answers to the questions and doubts asked by callers on various Health Problems. For More Updates ► TV5 News Live https://goo.gl/GI3neB ► Subscribe to TV5 News Channel: http://goo.gl/NHJD9 ► Download TV5 Android App: http://goo.gl/8mMEOX ►Our Website : http://www.tv5news.in ► Like us on Facebook: http://www.facebook.com/tv5newschannel ► Follow us on Twitter: https://twitter.com/tv5newsnow ► Circle us on TV5 News Channel G+: https://plus.google.com/+tv5newschannel ► Follow us on Pinterest: https://www.pinterest.com/tv5newschannel TV5 news is a 24 hours Telugu News Channel covering politics, sports, health, lifestyle and entertainment. TV5 news has 24 hours of news programs including Telugu news live, hourly news updates, Telangana news, Andhra Pradesh news updates, weather reports, exclusive interviews with celebrities, politicians and social activists and all important news updates from around the World
Views: 2694 TV5 News
Treatment with curative intent - Lung Cancer Forum, part 7 of 8
 
11:09
This video is part of a series of hypothetical case studies and expert panel discussions from the Lung Cancer Forum hosted by the Cancer Institute NSW in November 2007. The forum was designed to identify opportunities to improve the provision of healthcare delivery to patients with lung cancer.
Views: 57 cancerNSW
Dr. David Carbone on Immunotherapy Research in Lung Cancer
 
01:00
David P. Carbone, MD, PhD, a professor in the Division of Medical Oncology at the Ohio State University Comprehensive Cancer Center, discusses the exploration of immunotherapies as treatments for patients with advanced lung cancer. For more lung cancer resources, visit http://www.onclive.com/specialty/lung-cancer
Views: 257 OncLiveTV
The Lung Cancer Living Room™ - Lung Cancer Alliance Panel - Sep 27th, 2017  - Half-Hour Episode
 
27:23
In this special Lung Cancer Alliance Speaker Panel discussion held in Washington DC, join experts and industry professionals as they share their insights to advancing cancer care through research and advocacy.
Dr. Lynch on Targeting EGFR Mutation Subtypes in Lung Cancer
 
01:29
Thomas J. Lynch, MD, CEO, chairman, Massachusetts General Hospital Physicians Organization, discusses targeting EGFR mutation subtypes in frontline treatment for lung cancer.
Views: 267 OncLiveTV
Talking to Your Oncologist about Cancer Immunotherapy
 
50:42
When do most patients first learn about immunotherapy? How long can you start after your initial course of treatment? How does it feel to take part in a clinical trial? How do you anticipate and manage side effects?  In this webinar designed for patients and caregivers, Ariella Chivil, a patient advocate, and Alexander M. Lesokhin, M.D., her oncologist, discuss the nuances of communicating and informing both doctor and patient while on immunotherapy. They share their experiences with immunotherapy and answer viewer questions. Ariella Chivil is a patient advocate and cancer survivor. Diagnosed with Hodgkin lymphoma in 2010, she completed 14 different treatment protocols before entering a clinical trial of the immunotherapy nivolumab (Opdivo®). Her first scans after beginning the trial showed a marked reduction in her tumors. Today, Ariella is off treatment and enjoying living and working in New York City. Alexander M. Lesokhin, M.D., is a hematologic oncologist at Memorial Sloan Kettering Cancer Center who specializes in treating people with blood cancers such as lymphoma and multiple myeloma. Specifically, he’s focused on developing innovative ways to use the immune system to treat cancer and help these patients. The "Cancer Immunotherapy and You" webinar series is produced by the Cancer Research Institute and is made possible with generous support from Bristol-Myers Squibb, with additional support from Regeneron, Sanofi Genzyme, and Adaptimmune.
2017 Spring Symposium: Update on Cancer Immunotherapy
 
40:01
Jerrod Holmes M.D.: Update on Cancer Immunotherapy